Selank: Mechanism, Research Background, and Laboratory Use

What Is Selank?

Selank is a synthetic heptapeptide developed as an analog of tuftsin, the short Thr-Lys-Pro-Arg fragment of the human immunoglobulin G heavy chain. Researchers at the Institute of Molecular Genetics, Russian Academy of Sciences extended the tuftsin sequence with an added Pro-Gly-Pro tripeptide to improve metabolic stability and extend its duration of action in research settings, producing the heptapeptide studied today as Selank.

Mechanism of Action

Selank research has focused on its reported anxiolytic, antidepressant, and antistress activity. Gene-expression studies in rats found that intranasal Selank altered expression of dozens of genes involved in GABAergic neurotransmission — including GABA receptor subunits, GABA transporters, and genes involved in GABA synthesis and metabolism — within one to three hours of administration. Because Selank affected this broad panel of genes without evidence of directly binding GABA receptors, researchers concluded it most likely acts through allosteric modulation of GABAergic signaling rather than as a direct receptor agonist. Related cell-culture research examined Selank alongside GABA and olanzapine for effects on GABAergic gene expression in neuronal cell lines.

Research Background

Comparative rodent studies have reported that Selank produces anxiolytic, antidepressant, and antistress effects described as comparable to benzodiazepines such as diazepam, without the amnesia, withdrawal, or dependence typically associated with that drug class — though researchers note these comparisons come from the peptide’s original Russian development literature and should be treated as reported findings rather than independently confirmed equivalence claims. Because Selank shares its tuftsin-derived backbone with other immunomodulatory peptides, it is occasionally discussed in that broader research context as well, although its primary body of research to date is neuropharmacological. Selank is frequently studied and sold alongside Semax, a related Russian-developed nootropic heptapeptide, in comparative cognition- and mood-focused peptide research.

Laboratory Handling and Storage

Selank is typically supplied as a lyophilized (freeze-dried) powder or as a pre-formulated intranasal solution. Lyophilized powder should be stored refrigerated or frozen prior to reconstitution, protected from light and moisture; once reconstituted with bacteriostatic water, the solution should be kept refrigerated and used within the timeframe established by the researcher’s own protocol. Pre-formulated nasal spray solutions should likewise be stored refrigerated and protected from light per the supplier’s labeling. Standard laboratory peptide-handling practice — sterile technique, minimal freeze-thaw cycling, and accurate labeling with preparation date — applies to both formats.

Frequently Asked Questions

Disclaimer

This content is provided for laboratory research purposes only and is not intended as guidance for human or animal use. Selank, as sold by Pure Chain Aminos, is a research compound and is not evaluated or approved by the FDA for over-the-counter sale or self-administration. Nothing on this page constitutes medical advice, and no claims are made regarding safety or efficacy in humans or animals outside of a controlled research setting.

More compound research notes

• Semax: Mechanism, Research Background, and Laboratory Use
• Epitalon: Mechanism, Research Background, and Laboratory Use
• KPV: Mechanism, Research Background, and Laboratory Use
• Sermorelin: Mechanism, Research Background, and Laboratory Use
• CJC-1295: Mechanism, Research Background, and Laboratory Use
• Tesamorelin: Mechanism, Research Background, and Laboratory Use
• GHK-Cu: Mechanism, Research Background, and Laboratory Use
• Ipamorelin: Mechanism, Research Background, and Laboratory Use